Concerns regarding the use of efavirenz in patients with a history of mental illness may
predispose clinicians to not offer this agent to psychiatrically ill populations in spite of the …

Background Clozapine is an atypical antipsychotic that is beneficial to some patients who
failed to have an adequate clinical response to other antipsychotic drugs. Its clinical use is …

Background Clozapine is a unique anti-psychotic medication that is most effective in the
treatment of refractory schizophrenia and reducing suicidality. Cardiomyopathy is among the …

BACKGROUND: This is a systematic review of suicide and homicide-suicide events involving
aircraft. In aeromedical literature and in the media, these very different events are both …

Objective The haematological and cardiac complications of clozapine have been well
documented. Recent evidence from pharmacovigilance databases suggests that gastrointestinal (…

There is a lack of large randomized controlled studies to inform clinical practice. At present,
lithium and olanzapine probably represent the best choices for prophylaxis. Patients with a …

Methods This is a systematic review of the role of laboratory, radiologic, procedural, and
pathological modalities to assist in the diagnosis of factitious disorder (Munchausen's syndrome)…

Background Human immunodeficiency virus (HIV) disease can cause bereavement and
grief reactions brought about by the disease process itself and by the losses of loved ones. …

Objective Clozapine is the favoured antipsychotic for treatment‐refractory schizophrenia, but
has a 1%‐2% incidence of agranulocytosis. Patients who require chemotherapy therefore …

Background We describe the first case of a patient with factitious disorder who closely
simulated a primary immune deficiency disorder – Common Variable Immune Deficiency (CVID), …